Dive Brief: The Food and Drug Administration granted conditional approval to Eli Lilly’s oral cancer drug Jaypirca in two types...
Medicine
Dive Brief: BioMarin Pharmaceutical has reached an agreement with German authorities on a price for Roctavian, more than one year...
The Food and Drug Administration’s top scientist Namandjé Bumpus will assume the role of principal deputy commissioner when longtime agency...
Dive Brief: A contract research organization working for biotechnology company Acelyrin is disputing suggestions that it may be responsible for...
Dive Brief: Pfizer will not advance a twice-daily dose of an experimental obesity drug into further testing after results from...
Dive Brief: Concentra Biosciences has made an unsolicited bid to acquire all outstanding shares of LianBio, a biotechnology company focused...
Europe’s drug regulator has more questions about the safety and potential risks of a new, widely popular class of medicines....
Flagship Pioneering is looking to raise $3 billion for its eighth venture fund, a sign the high-profile company creator continues...
AbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion deal to acquire ImmunoGen, a pioneer...
Dive Brief: Cigna and Humana are in talks to merge, according to the Wall Street Journal. The two health insurers...